Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NCCAM St. John's wort study

This article was originally published in The Tan Sheet

Executive Summary

The NIH National Center for Complementary & Alternative Medicine is recruiting patients for its upcoming study on St. John's wort via a notice on its Web site. "Are you suffering from depression? Are you thinking of trying the popular herbal antidepressant St. John's wort, but you aren't sure how to take it or whether it will work? If so, you may want to participate in the St. John's wort study that the National Institutes of Health is funding," the notice says. The study has recruited about half of its participants (1"The Tan Sheet" Sept. 6, p. 12)

You may also be interested in...

NCCAM Advisory Council Approves Center's First Three Project Initiatives

The newly chartered National Advisory Council for Complementary & Alternative Medicine unanimously approved a project proposal entitled "Traditional, Indigenous Systems of Medicine" at its inaugural meeting Aug. 31-Sept. 1 in Rockville, Md.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts